Download PDF
Thromb Haemost 2012; 107(06): 1100-1106
DOI: 10.1160/TH11-10-0721
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists

Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)
Daniela Poli
1   Thrombosis Centre Department of Heart and Vessels, AOU-Careggi, Florence, Italy
,
Emilia Antonucci
2   Department of Medical and Surgical Critical Care University of Florence, Italy
,
Maria Zanazzi
3   Renal Unit, AOU-Careggi, Florence, Italy
,
Elisa Grifoni
2   Department of Medical and Surgical Critical Care University of Florence, Italy
,
Sophie Testa
4   Haemostasis and Thrombosis Centre A O Istituti Ospitalieri di Cremona, Cremona, Italy
,
Walter Ageno
5   Department of Clinical Medicine University of Insubria, Varese, Italy
,
Gualtiero Palareti
6   Department of Angiology and Blood Coagulation ″Marino Golinelli“, University Hospital S. Orsola-Malpighi, Bologna, Italy
› Author Affiliations
Further Information

Publication History

Received: 20 October 2011

Accepted after major revision: 09 April 2012

Publication Date:
29 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

Vitamin K antagonists (VKA) therapy is increasingly used in elderly for prevention of venous thromboembolism (VTE) and of stroke in atrial fibrillation (AF). Glomerular filtration rate (GFR), usually estimated from different equations, decreases progressively with age and it is a risk factor for bleeding. In the frame of the EPICA study, a multicentre prospective observational study including 4,093 patients ≥80 years naïve to VKA treated for AF or after VTE, we performed this ancillary study to evaluate the prevalence of chronic kidney diseases (CKD) by estimated GFR (eGFR). Incidence of bleedings was recorded and bleeding risk was evaluated in relation to eGFR calculated by Cockroft-Gault (C-G); Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas. In addition, the agreement among the three eGFR formulas was evaluated. We recorded 179 major bleedings (rate 1.87 x100 patient-years [py]), 26 fatal (rate 0.27 x100 py). Moderate CKD was detected in 69.3%, 59.3% and 47.0% and severe CKD in 5.8%, 7.4% and 10.0% of cases by C-G, MDRD and CKD-EPI, respectively. Bleeding risk was higher in patients with severe CKD irrespective of the applied equation. This study confirms that CKD represents an independent risk factor for bleeding and that a wide proportion of elderly on VKA had severe or moderate CKD, suggesting the need for frequent monitoring. Although the different available equations yield different eGFR, all appear to similarly predict the risk of major bleeding.

Keywords

Bleeding - elderly - glomerular filtration rate - VKA treatment

* Collaborators listed in full in the Appendix.


 

  • References

  • 1 Mant J, Hobbs FD, Fletcher K. et al. Midland Research Practices Network (Mid-ReC) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
    CrossrefPubMedGoogle Scholar
  • 2 Olesen JB, Lip GY, Lindhardsen J. et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost 2011; 106: 739-749.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Douville P, Martel AR, Talbot J. et al. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant 2009; 24: 97-103.
    PubMedGoogle Scholar
  • 4 Pereira BJ. Introduction: new perspectives in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S1-3.
    PubMedGoogle Scholar
  • 5 Rosamond W, Flegal K, Furie K. et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
    CrossrefPubMedGoogle Scholar
  • 6 Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-99.
    CrossrefPubMedGoogle Scholar
  • 7 Gage BF, Yan Y, Milligan PE. et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006; 151: 713-719.
    CrossrefPubMedGoogle Scholar
  • 8 Pisters R, Lane DA, Nieuwlaat R. et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100.
    CrossrefPubMedGoogle Scholar
  • 9 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
    CrossrefPubMedGoogle Scholar
  • 10 European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Camm AJ, Kirchhof P, Lip GY. et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1342.
    CrossrefPubMedGoogle Scholar
  • 11 You JJ, Singer DE, Howard PA. et al. Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e531S-575S.
    CrossrefPubMedGoogle Scholar
  • 12 Levey AS, Bosch JP, Lewis JB. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 1999; 130: 461-470.
    PubMedGoogle Scholar
  • 13 Levey AS, Coresh J, Greene T. et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
    CrossrefPubMedGoogle Scholar
  • 14 Levey AS, Stevens LA, Schmid CH. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
    CrossrefPubMedGoogle Scholar
  • 15 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002 39. S1-266.
    PubMedGoogle Scholar
  • 16 Gouin-Thibault I, Pautas E, Mahé I. et al. Is Modification o f Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?. J Gerontol A Biol Sci Med Sci 2007; 62: 1300-1305.
    CrossrefPubMedGoogle Scholar
  • 17 Spruill WJ, Wade WE, Cobb 3rd HH. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009; 86: 468-470.
    CrossrefPubMedGoogle Scholar
  • 18 Poli D, Antonucci E, Testa S. et al. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation 2011; 124: 824-829.
    CrossrefPubMedGoogle Scholar
  • 19 Tripodi A, Chantarangkul V, Akkawat B. et al. A partial factor V deficiency in anti-coagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme. Thromb Res 1995; 78: 283-292.
    CrossrefPubMedGoogle Scholar
  • 20 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 26: S5-20.
    PubMedGoogle Scholar
  • 21 Rosendaal FR, Cannegieter SC, van der Meer FJM. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
    PubMedGoogle Scholar
  • 23 Palareti G, Hirsh J, Legnani C. et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000; 160: 470-478.
    CrossrefPubMedGoogle Scholar
  • 24 Garcia DA, Lopes RD, Hylek EM. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Thromb Haemost 2010; 104: 1099-1105.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Duncan L, Heathcote J, Djurdjev O. et al. Screening for renal disease using serum creatinine: who are we missing?. Nephrol Dial Transplant 2001; 16: 1042-1046.
    CrossrefPubMedGoogle Scholar
  • 26 Swedko PJ, Clark HD, Paramsothy K. et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003; 163: 356-360.
    CrossrefPubMedGoogle Scholar
  • 27 Rimon E, Kagansky N, Cojocaru L. et al. Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients?. QJM 2004; 97: 281-287.
    CrossrefPubMedGoogle Scholar
  • 28 Pedone C, Corsonello A, Incalzi RA. GIFA Investigators. Estimating renal function in older people: a comparison of three formulas. Age Ageing 2006; 35: 121-126.
    CrossrefPubMedGoogle Scholar
  • 29 Nygaard HA, Naik M, Ruths S. et al. Clinically important renal impairment in various groups of old persons. Scand J Prim Health Care 2004; 22: 152-156.
    CrossrefPubMedGoogle Scholar
  • 30 Michels WM, Grootendorst DC, Verduijn M. et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010; 5: 1003-1009.
    CrossrefPubMedGoogle Scholar
  • 31 Corsonello A, Pedone C, Lattanzio F. et al. Chronic kidney disease and 1-year survival in elderly patients discharged from acute care hospitals: a comparison of three glomerular filtration rate equations. Nephrol Dial Transplant 2011; 26: 360-364.
    CrossrefPubMedGoogle Scholar
  • 32 Falga C, Capdevila JA, Soler S. et al. Clinical outcome of patients with venous thromboembolism and renal insufficiency: Findings from the RIETE registry. Thromb Haemost 2007; 98: 771-776.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Lip GY, Andreotti F, Fauchier L. et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost 2011; 106: 997-1011.
    PubMedGoogle Scholar
  • 34 Monreal M, Falgá C, Valle R. et al. Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med 2006; 119: 1073-1079.
    CrossrefPubMedGoogle Scholar
  • 35 Melloni C, Peterson ED, Chen AY. et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008; 51: 991-996.
    CrossrefPubMedGoogle Scholar
  • 36 Roberts GW, Ibsen PM, Schiøler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009; 38: 698-703.
    CrossrefPubMedGoogle Scholar